QuestionSBA
QuestionChoice
This is the mode of action of the -gliflozins, such as empagliflozin. Sitagliptin inhibits DPP-4, increasing incretin levels which inhibits glucagon secretion.
10004634
d
Sitagliptin inhibits SGLT-2, thereby inhibiting the reabsorption of glucose by the kidneys
QuestionChoice
Although insulin is primarily used in patients with type 1 diabetes mellitus, it is also sometimes used in patients with poorly controlled type 2 diabetes mellitus.
10004631
a
Subcutaneous insulin is a direct replacement for endogenous insulin
QuestionChoice
This is the mode of action of the -gliptins, such as sitagliptin. Empagliflozin inhibits SGLT-2, thereby inhibiting the reabsorption of glucose by the kidneys.
10004633
c
Empagliflozin inhibits the enzyme DPP-4, resulting in the inhibition of glucagon secretion
QuestionChoice
Metformin is the first-line medication used in type 2 diabetes mellitus, however, it works by increasing peripheral sensitivity to insulin and decreasing hepatic gluconeogenesis.
10004632
b
Metformin is the first line medication used in type 2 diabetes mellitus- it stimulates the pancreatic beta cells to secrete insulin
QuestionChoice
This is the mode of action of metformin, the first-line medication used in type 2 diabetes mellitus. Gliclazide is a sulfonylurea, which stimulates the pancreatic beta cells to secrete more insulin.
10004635
e
Gliclazide works by increasing peripheral sensitivity to insulin and decreasing hepatic gluconeogenesis
Concept
Chapter
2693
3761
Type 2 Diabetes Mellitus
Topic
133
Endocrinology
13473
Which of the following statements correctly describes a medication used in the treatment of type 2 diabetes mellitus?
a